vs
Allegiant Travel CO（ALGT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Allegiant Travel CO的季度营收约是Royalty Pharma plc的1.2倍（$732.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 5.8%，领先28.6%），Royalty Pharma plc同比增速更快（4.8% vs 4.8%），过去两年Allegiant Travel CO的营收复合增速更高（11.0% vs 4.6%）
忠实航空是美国的一家低成本航空公司，总部位于内华达州拉斯维加斯。该航司主打超低成本运营模式，基础票价包含服务极少，通过大量附加服务收取额外费用，核心服务对象是中小城市尚未被充分覆盖的休闲出行客流。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ALGT vs RPRX — 直观对比
营收规模更大
ALGT
是对方的1.2倍
$622.0M
营收增速更快
RPRX
高出0.0%
4.8%
净利率更高
RPRX
高出28.6%
5.8%
两年增速更快
ALGT
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $732.4M | $622.0M |
| 净利润 | $42.5M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 11.1% | 62.4% |
| 净利率 | 5.8% | 34.4% |
| 营收同比 | 4.8% | 4.8% |
| 净利润同比 | 32.4% | 2.9% |
| 每股收益（稀释后） | $2.30 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGTRPRX
| Q1 26 | $732.4M | — | ||
| Q4 25 | $595.5M | $622.0M | ||
| Q3 25 | $494.1M | $609.3M | ||
| Q2 25 | $617.9M | $578.7M | ||
| Q1 25 | $616.8M | $568.2M | ||
| Q4 24 | $553.6M | $593.6M | ||
| Q3 24 | $489.0M | $564.7M | ||
| Q2 24 | $594.5M | $537.3M |
净利润ALGTRPRX
| Q1 26 | $42.5M | — | ||
| Q4 25 | $31.9M | $214.2M | ||
| Q3 25 | $-43.6M | $288.2M | ||
| Q2 25 | $-65.2M | $30.2M | ||
| Q1 25 | $32.1M | $238.3M | ||
| Q4 24 | $-216.2M | $208.2M | ||
| Q3 24 | $-36.8M | $544.0M | ||
| Q2 24 | $13.7M | $102.0M |
营业利润率ALGTRPRX
| Q1 26 | 11.1% | — | ||
| Q4 25 | 11.2% | 62.4% | ||
| Q3 25 | -5.5% | 70.1% | ||
| Q2 25 | -10.9% | 36.3% | ||
| Q1 25 | 10.5% | 94.0% | ||
| Q4 24 | -47.7% | 60.9% | ||
| Q3 24 | -5.4% | — | ||
| Q2 24 | 5.9% | 50.2% |
净利率ALGTRPRX
| Q1 26 | 5.8% | — | ||
| Q4 25 | 5.4% | 34.4% | ||
| Q3 25 | -8.8% | 47.3% | ||
| Q2 25 | -10.5% | 5.2% | ||
| Q1 25 | 5.2% | 41.9% | ||
| Q4 24 | -39.1% | 35.1% | ||
| Q3 24 | -7.5% | 96.3% | ||
| Q2 24 | 2.3% | 19.0% |
每股收益（稀释后）ALGTRPRX
| Q1 26 | $2.30 | — | ||
| Q4 25 | $1.82 | $0.49 | ||
| Q3 25 | $-2.41 | $0.67 | ||
| Q2 25 | $-3.62 | $0.07 | ||
| Q1 25 | $1.73 | $0.55 | ||
| Q4 24 | $-12.12 | $0.46 | ||
| Q3 24 | $-2.05 | $1.21 | ||
| Q2 24 | $0.75 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $902.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | — | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ALGTRPRX
| Q1 26 | $902.1M | — | ||
| Q4 25 | $805.7M | $618.7M | ||
| Q3 25 | $956.7M | $938.9M | ||
| Q2 25 | $842.8M | $631.9M | ||
| Q1 25 | $878.6M | $1.1B | ||
| Q4 24 | $781.1M | $929.0M | ||
| Q3 24 | $759.3M | $950.1M | ||
| Q2 24 | $791.9M | $1.8B |
总债务ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $9.0B | ||
| Q3 25 | $1.8B | $8.9B | ||
| Q2 25 | $1.8B | $8.0B | ||
| Q1 25 | $1.7B | $7.6B | ||
| Q4 24 | $1.6B | $7.6B | ||
| Q3 24 | $1.8B | $7.6B | ||
| Q2 24 | $1.7B | $7.6B |
股东权益ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $9.7B | ||
| Q3 25 | $1.0B | $9.6B | ||
| Q2 25 | $1.1B | $9.5B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $1.1B | $10.3B | ||
| Q3 24 | $1.3B | $10.3B | ||
| Q2 24 | $1.3B | $9.8B |
总资产ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $19.6B | ||
| Q3 25 | $4.4B | $19.3B | ||
| Q2 25 | $4.4B | $18.3B | ||
| Q1 25 | $4.5B | $17.6B | ||
| Q4 24 | $4.4B | $18.2B | ||
| Q3 24 | $4.8B | $18.0B | ||
| Q2 24 | $4.9B | $17.7B |
负债/权益比ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 1.60× | 0.92× | ||
| Q3 25 | 1.76× | 0.93× | ||
| Q2 25 | 1.68× | 0.84× | ||
| Q1 25 | 1.57× | 0.78× | ||
| Q4 24 | 1.48× | 0.74× | ||
| Q3 24 | 1.36× | 0.74× | ||
| Q2 24 | 1.30× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | $112.2M | $827.1M | ||
| Q3 25 | $-6.1M | $702.6M | ||
| Q2 25 | $92.2M | $364.0M | ||
| Q1 25 | $191.4M | $596.1M | ||
| Q4 24 | $84.4M | $742.5M | ||
| Q3 24 | $17.3M | $703.6M | ||
| Q2 24 | $68.9M | $658.2M |
自由现金流ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | $90.4M | — | ||
| Q3 25 | $-121.7M | — | ||
| Q2 25 | $-10.5M | — | ||
| Q1 25 | $116.9M | — | ||
| Q4 24 | $24.0M | — | ||
| Q3 24 | $-28.7M | — | ||
| Q2 24 | $7.0M | — |
自由现金流率ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 15.2% | — | ||
| Q3 25 | -24.6% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | 19.0% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | -5.9% | — | ||
| Q2 24 | 1.2% | — |
资本支出强度ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 16.6% | — | ||
| Q1 25 | 12.1% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 10.4% | — |
现金转化率ALGTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 3.51× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 5.96× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 5.03× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALGT
| Passenger | $671.8M | 92% |
| Third party products | $42.3M | 6% |
| Fixed fee contracts | $18.1M | 2% |
| Resort and other | $175.0K | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
